Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study.

Tiselius C, Gunnarsson U, Smedh K, Glimelius B, Påhlman L.

Ann Oncol. 2013 Jan;24(1):160-5. doi: 10.1093/annonc/mds278. Epub 2012 Aug 16.

PMID:
22904238
2.

Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.

Law WL, Ho JW, Chan R, Au G, Chu KW.

Dis Colon Rectum. 2005 Feb;48(2):218-26.

PMID:
15711860
3.

Use of adjuvant chemotherapy in stage C (III) rectal cancer: comparison of data from matched patients in a teaching hospital's clinico-pathological database.

Kho P, Chapuis PH, Beale P, Bokey L, Dent OF, Clarke S.

Asia Pac J Clin Oncol. 2012 Dec;8(4):346-55. doi: 10.1111/j.1743-7563.2012.01519.x. Epub 2012 Apr 23.

PMID:
22897797
4.

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.

Breugom AJ, van Gijn W, Muller EW, Berglund Å, van den Broek CB, Fokstuen T, Gelderblom H, Kapiteijn E, Leer JW, Marijnen CA, Martijn H, Meershoek-Klein Kranenbarg E, Nagtegaal ID, Påhlman L, Punt CJ, Putter H, Roodvoets AG, Rutten HJ, Steup WH, Glimelius B, van de Velde CJ; Cooperative Investigators of Dutch Colorectal Cancer Group and Nordic Gastrointestinal Tumour Adjuvant Therapy Group.

Ann Oncol. 2015 Apr;26(4):696-701. doi: 10.1093/annonc/mdu560. Epub 2014 Dec 5.

PMID:
25480874
5.

Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

Khrizman P, Niland JC, ter Veer A, Milne D, Bullard Dunn K, Carson WE 3rd, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB 3rd.

J Clin Oncol. 2013 Jan 1;31(1):30-8. doi: 10.1200/JCO.2011.40.3188. Epub 2012 Nov 19.

PMID:
23169502
6.

Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.

Yang L, Ma Q, Yu YY, Wang C, Meng WJ, Adell G, Albertsson M, Arbman G, Jarlsfelt I, Peng ZH, Li Y, Zhou ZG, Sun XF.

Medicine (Baltimore). 2014 Dec;93(28):e266. doi: 10.1097/MD.0000000000000266.

7.

EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy.

Chand M, Bhangu A, Wotherspoon A, Stamp GW, Swift RI, Chau I, Tekkis PP, Brown G.

Ann Oncol. 2014 Apr;25(4):858-63. doi: 10.1093/annonc/mdu029.

PMID:
24667718
8.

Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.

van Erning FN, Rutten HJ, van den Berg HA, Lemmens VE, van Halteren HK.

Eur J Surg Oncol. 2015 Dec;41(12):1630-5. doi: 10.1016/j.ejso.2015.09.011. Epub 2015 Sep 26.

PMID:
26437853
9.

lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.

Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):796-802. doi: 10.1016/j.ijrobp.2008.08.065. Epub 2009 Mar 14.

PMID:
19289261
10.

Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival.

Tevis SE, Kohlnhofer BM, Stringfield S, Foley EF, Harms BA, Heise CP, Kennedy GD.

Dis Colon Rectum. 2013 Dec;56(12):1339-48. doi: 10.1097/DCR.0b013e3182a857eb.

11.

[Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].

Rougier P, Mitry E, Clavéro-Fabri MC, Penna C, Nordlinger B.

Ann Chir. 1999;53(10):1011-8. Review. French.

PMID:
10670150
12.

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.

Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM; Norwegian Gastrointestinal Cancer Group.

Acta Oncol. 2009;48(3):368-76. doi: 10.1080/02841860902755244.

PMID:
19242829
13.

Palliative resection of the primary tumour in stage IV rectal cancer.

Verberne CJ, de Bock GH, Pijl ME, Baas PC, Siesling S, Wiggers T.

Colorectal Dis. 2012 Mar;14(3):314-9. doi: 10.1111/j.1463-1318.2011.02618.x.

PMID:
21689309
14.

A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.

Gelber RD, Goldhirsch A, Cole BF, Wieand HS, Schroeder G, Krook JE.

J Natl Cancer Inst. 1996 Aug 7;88(15):1039-45.

PMID:
8683634
15.

A population-based study elicits a reverse correlation between age and overall survival in elderly patients with rectal carcinoma receiving adjuvant chemotherapy.

Shan JL, Li Q, He ZX, Ren T, Zhou SF, Wang D.

Clin Exp Pharmacol Physiol. 2015 Jul;42(7):752-65. doi: 10.1111/1440-1681.12420.

PMID:
25966617
16.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
17.

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Ströbel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, Liersch T; German Rectal Cancer Study Group.

Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.

PMID:
26189067
18.

Adjuvant chemotherapy improves overall survival after TME surgery in mucinous carcinoma of the rectum.

Chand M, Rasheed S, Bhangu A, Stamp GW, Swift RI, Tekkis PP, Brown G.

Eur J Surg Oncol. 2014 Feb;40(2):240-5. doi: 10.1016/j.ejso.2013.11.005. Epub 2013 Nov 12.

PMID:
24286808
19.

Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.

Becerra AZ, Probst CP, Tejani MA, Aquina CT, González MG, Hensley BJ, Noyes K, Monson JR, Fleming FJ.

Surgery. 2015 Sep;158(3):692-9. doi: 10.1016/j.surg.2015.03.057. Epub 2015 May 29.

PMID:
26032822

Supplemental Content

Support Center